Febrile urinary tract infections in children, N Engl J Med, vol.365, pp.239-250, 2011. ,
Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up, BMJ, vol.299, pp.703-706, 1989. ,
Early Antibiotic Treatment for Pediatric Febrile Urinary Tract Infection and Renal Scarring, JAMA Pediatr, vol.170, pp.848-854, 2016. ,
Epidemiology and characteristics of urinary tract infections in children and adolescents, Front Cell Infect Microbiol, vol.5, p.45, 2015. ,
Diagnosis and management of pediatric urinary tract infections, Clin Microbiol Rev, vol.18, pp.417-422, 2005. ,
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern, Lancet Infect Dis, vol.8, pp.70041-70041, 2008. ,
Treatment of resistant bacterial infections in children: thinking inside and outside the box, Adv Exp Med Biol, vol.764, pp.123-132, 2013. ,
Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli, Arch Intern Med, vol.168, pp.1897-1902, 2008. ,
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae, Infect Control Hosp Epidemiol, vol.29, pp.671-674, 2008. ,
The Widespread Presence of a Multidrug-Resistant Escherichia coli ST131 Clade among Community-Associated and Hospitalized Patients, PLoS One, vol.11, issue.0150420, 2016. ,
Circulation of clonal populations of fluoroquinolone-resistant CTX-M-15-producing Escherichia coli ST410 in humans and animals in Germany, Int J Antimicrob Agents, vol.47, pp.457-465, 2016. ,
, Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months, Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB, vol.128, pp.595-610, 2011.
Diagnosis and management of urinary tract infection in children: summary of NICE guidance, BMJ, vol.335, pp.395-397, 2007. ,
Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother, vol.57, pp.1488-1495, 2013. ,
, Escherichia coli Harboring mcr-1 and blaCTX-M on a Novel IncF Plasmid: First Report of mcr-1 in the United States, vol.60, pp.4420-4421, 2016.
Extended-spectrum beta-lactamaseproducing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?, Int Infect Dis, vol.39, pp.62-67, 2015. ,
,
Management of urinary tract infections in children. Recommendations of the Pediatric Infectious Diseases Group of the French Pediatrics Society and the French-Language Infectious Diseases Society, Arch Pediatr, vol.22, pp.665-671, 2015. ,
Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires du nourrisson et de l'enfant, 2007. ,
Urinary tract infections in children: EAU/ESPU guidelines, Eur Urol, vol.67, pp.546-558, 2015. ,
Extended-spectrum ?-lactamase-producing bacteria causing community-acquired urinary tract infections in children, Pediatr Nephrol, vol.29, p.24705795, 2014. ,
Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in French children, BMC Infect Dis, vol.12, p.315, 2012. ,
, Recommandations du comité de l'antibiogramme de la société française de microbiologie, 2014.
Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide, Clin Microbiol Infect, vol.14, pp.90-103, 2008. ,
In vitro interaction between cefixime and amoxicillin-clavulanate against extended-spectrum-betalactamase-producing Escherichia coli causing urinary tract infection, J Clin Microbiol, vol.50, pp.2540-2541, 2012. ,
Optimizing aminoglycoside use, Crit Care Clin, vol.27, pp.107-121, 2011. ,
Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum ?-lactamase-producing Escherichia coli or Klebsiella pneumoniae, BMC Infect Dis, vol.15, p.26464143, 2015. ,
Aminoglycosides Monotherapy as First-Line Treatment for Febrile Urinary Tract Infection in Children, Pediatr Infect Dis. J, 2017. ,
, Mise au point sur le bon usage des aminosides administrés par voie injectable : gentamicine, tobramycine, nétilmicine, amikacine, ANSM (Agence nationale de sécurité du médicament et des produits de santé), 2011.
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011, Clin Ther, vol.35, pp.872-877, 2013. ,
The use of piperacillin-tazobactam in neonatal and paediatric patients, Expert Opin Drug Metab Toxicol, vol.5, pp.57-69, 2009. ,
Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae, Plos One, vol.11, 2016. ,
Temocillin revived, J Antimicrob Chemother, vol.63, pp.243-245, 2009. ,
Activity of temocillin in a murine model of urinary tract infection due to ,
, J Antimicrob Chemother, vol.70, pp.1466-1472, 2015.
Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials, J Antimicrobial Chemother, vol.65, pp.1862-1877, 2010. ,
Nitrofirantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients, J Antimicrob Chemother, vol.69, pp.3259-3262, 2014. ,
The Use of Noncarbapenem ?-Lactams for the Treatment of Extended-Spectrum ?-Lactamase Infections, Clin Infect Dis, vol.64, pp.972-980, 2017. ,
New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?, Clin Microbiol Infect, 2017. ,
In vitro interaction between cefixime and amoxicillin-clavulanate against extended-spectrum-beta-lactamase-producing Escherichia coli causing urinary tract infection, J Clin Microbiol, vol.50, pp.2540-2541, 2012. ,
Combined relay therapy with oral cefixime and clavulanate for febrile urinary tract infection caused by extended-spectrum ?-lactamase-producing Escherichia coli, Pediatr Infect Dis J, vol.32, pp.96-97, 2013. ,
Long-term outcomes of inappropriate antibiotic therapy for upper urinary tract infections caused by extended-spectrum betalactamase-producing Enterobacteriaceae: a retrospective cohort study, Diagn Microbiol Infect Dis, 2017. ,
Effect of ceftriaxone on the outcome of murine pyelonephritis caused by extended-spectrum-?-lactamase-producing Escherichia coli, Antimicrob Agents Chemother, vol.58, pp.3974-3988, 2014. ,
Antimicrobial Susceptibility Patterns Among Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in a Large Pediatric Hospital in the United Kingdom, J Pediatric Infect Dis Soc, vol.4, pp.147-150, 2015. ,
Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, Diagn Microbiol Infect Dis, vol.85, pp.459-465, 2016. ,
Inventory of Extended-Spectrum-?-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study, Antimicrob Agents Chemother, issue.3, p.61, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01595458
Childhood urinary tract infection caused by extendedspectrum ?-lactamase-producing bacteria: Risk factors and empiric therapy, Pediatr Int, vol.59, pp.176-180, 2017. ,
Community-Onset Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France, Medicine (Baltimore), vol.95, p.3163, 2016. ,
Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis, J Infect, 2016. ,
National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience, J Antimicrobio Chemother, vol.68, pp.954-959, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00802748
Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection, Pediatr Infect Dis J, vol.20, pp.507-511, 2001. ,